MicroRNAs profiling in fibroblasts derived from patients with Gorlin syndrome

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Gorlin syndrome (GS) is an inherited disorder characterized by tumor development due to overactive hedgehog signaling.
• Current treatments using Smoothened (SMO) antagonists face challenges like severe side effects and drug resistance.

Purpose of the Study:

• To investigate microRNAs in Gorlin syndrome fibroblasts as potential therapeutic targets for controlling hedgehog signaling.
• To identify novel microRNAs involved in the pathogenesis of Gorlin syndrome.

Main Methods:

• Microarray comparative genomic hybridization was used to screen 632 microRNAs in dermal fibroblasts from GS patients and controls.
• Real-time PCR was employed to validate the expression levels of specific microRNAs, including hsa-miR-196a-5p and hsa-miR-4485.
• Analysis of MAP3K1 expression at mRNA and protein levels in GS fibroblasts.

Main Results:

• 16 microRNAs were downregulated and 19 were upregulated (over twofold change) in GS fibroblasts.
• Hsa-miR-196a-5p was confirmed to be downregulated, while hsa-miR-4485 was upregulated in GS fibroblasts.
• Downregulated hsa-miR-196a-5p correlated with upregulated MAP3K1, a known activator of hedgehog signaling, suggesting a positive feedback loop.

Conclusions:

• Hsa-miR-196a-5p may play a role in the positive feedback loop of hedgehog signaling in Gorlin syndrome.
• Identifying microRNA dysregulation provides potential new therapeutic targets for Gorlin syndrome and related cancers.
• Further research into the hsa-miR-196a-5p/MAP3K1 axis could lead to novel treatment strategies for hedgehog pathway-driven tumorigenesis.